Cybin is trading 6.35% up at $14.91 in pre-market, apparently amid broad risk-on sentiment rather than a new company-specific announcement.
- Cybin advanced 4.08% to $14.02 on September 17, 2026.
- The Nasdaq Composite is up 0.60%, as investors respond positively to easing oil and Treasury yields.
- No verified September 17 post-close announcement was identified; Cybin’s Morgan Stanley healthcare presentation occurred on September 16, not overnight.